首页> 外文期刊>Molecular and Cellular Biology >Progesterone Inhibits Estrogen-Induced Cyclin D1 and cdk4 Nuclear Translocation, Cyclin E- and Cyclin A-cdk2 Kinase Activation, and Cell Proliferation in Uterine Epithelial Cells in Mice
【24h】

Progesterone Inhibits Estrogen-Induced Cyclin D1 and cdk4 Nuclear Translocation, Cyclin E- and Cyclin A-cdk2 Kinase Activation, and Cell Proliferation in Uterine Epithelial Cells in Mice

机译:孕酮抑制雌激素诱导的Cyclin D1和cdk4核易位,Cyclin E和Cyclin A-cdk2激酶激活以及小鼠子宫上皮细胞的细胞增殖。

获取原文
           

摘要

The response of the uterine epithelium to female sex steroid hormones provides an excellent model to study cell proliferation in vivo since both stimulation and inhibition of cell proliferation can be studied. Thus, when administered to ovariectomized adult mice 17β-estradiol (E2) stimulates a synchronized wave of DNA synthesis and cell division in the epithelial cells, while pretreatment with progesterone (P4) completely inhibits this E2-induced cell proliferation. Using a simple method to isolate the uterine epithelium with high purity, we have shown that E2 treatment induces a relocalization of cyclin D1 and, to a lesser extent, cdk4 from the cytoplasm into the nucleus and results in the orderly activation of cyclin E- and cyclin A-cdk2 kinases and hyperphosphorylation of pRb and p107. P4 pretreatment did not alter overall levels of cyclin D1, cdk4, or cdk6 nor their associated kinase activities but instead inhibited the E2-induced nuclear localization of cyclin D1 to below the control level and, to a lesser extent, nuclear cdk4 levels, with a consequent inhibition of pRb and p107 phosphorylation. In addition, it abrogated E2-induced cyclin E-cdk2 activation by dephosphorylation of cdk2, followed by inhibition of cyclin A expression and consequently of cyclin A-cdk2 kinase activity and further inhibition of phosphorylation of pRb and p107. P4is used therapeutically to oppose the effect of E2 during hormone replacement therapy and in the treatment of uterine adenocarcinoma. This study showing a novel mechanism of cell cycle inhibition by P4 may provide the basis for the development of new antiestrogens.
机译:子宫上皮对女性性类固醇激素的反应为研究体内细胞增殖提供了一个极好的模型,因为可以研究细胞增殖的刺激和抑制。因此,当给予去卵巢的成年小鼠17β-雌二醇(E 2 )刺激上皮细胞DNA合成和细胞分裂的同步波,而孕酮(P 4 )完全抑制这种E 2 诱导的细胞增殖。使用一种简单的方法以高纯度分离子宫上皮,我们显示E 2 处理可诱导细胞周期蛋白D1重新定位,并在较小程度上诱导cdk4从细胞质进入细胞核并导致细胞周期蛋白E和细胞周期蛋白A-cdk2激酶的有序激活和pRb和p107的过度磷酸化。 P 4 预处理不会改变细胞周期蛋白D1,cdk4或cdk6的总体水平,也不改变其相关激酶活性,而是将E 2 诱导的细胞周期蛋白D1的核定位抑制到低于控制水平,并在较小程度上控制核cdk4水平,从而抑制pRb和p107磷酸化。此外,它通过cdk2的去磷酸化消除了E 2 诱导的cyclin E-cdk2活化,随后抑制了cyclin A的表达,进而抑制了cyclin A-cdk2激酶的活性,并进一步抑制了pRb和pRb的磷酸化。 107在激素替代疗法和子宫腺癌的治疗中,P 4 用于对抗E 2 的作用。这项研究表明P 4 抑制细胞周期的新机制可能为开发新型抗雌激素提供基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号